K Number
K213578
Date Cleared
2022-04-06

(147 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Balloon Dilatation Catheter is intended to endoscopically dilate strictures of the alimentary tract. The device is supplied sterile and intended for single use only.

Device Description

The proposed device Balloon Dilatation Catheter is comprised of a pebax balloon mounted at the distal end of a pebax catheter with two ports. The balloon can be inflated to three distinct sizes, 6-7-8mm, 8-9-10mm, 10-11-12mm, 12-13.5-15mm, 15-16.5-18mm, 18-19-20mm diameters; the balloon length can be 30mm, 55mm and 80mm. Radiopaque bands placed at the distal and proximal end of the device provide fluoroscopic visualization of the balloon location. The catheter length is 1800mm, 1950mm, 2100mm and 2400mm with an outer diameter of 1.8mm, 2.0mm or 2.3mm. The two ports correspond to a guide wire port and balloon inflation port. A stopcock is included at the proximal end of the balloon inflation port to control pressure movement into or out of the device. For rapid exchange models, there is a small hole on the catheter which is about 200mm far away from the distal end, it is used to insert the guide wire rapidly. The Balloon Dilatation Catheter is EO sterilization and use for single use only.

AI/ML Overview

Here's a breakdown of the acceptance criteria and study information based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria (Implied from Performance Data)Reported Device Performance
Biocompatibility (ISO 10993)Device meets all standards
Sterility (ISO 11135)Device meets all standards
Head tip of the distal endMeets design specifications
Connect strengthMeets design specifications
Leakage performanceMeets design specifications
Balloon fatigue performanceMeets design specifications
Balloon position detectabilityMeets design specifications
Interface compatibility with endoscopeMeets design specifications
Compatibility with guide wireMeets design specifications
Compatibility with luer taperMeets design specifications

Note on Acceptance Criteria: The document explicitly states "The Balloon Dilatation Catheter meets all design specifications and medical device standards for biocompatibility (ISO 10993) and sterility (ISO 11135)". For the other items listed under "Following tests were conducted in our non-clinical bench test," the document states "The non-clinical performance meets the design specification and shows substantial equivalence to the predicated device." This implies that the acceptance criterion for these tests was to meet their respective design specifications.

2. Sample Size Used for the Test Set and Data Provenance

The document does not explicitly state the sample sizes used for the non-clinical bench tests. It also does not provide information on the provenance of data for these tests (e.g., country of origin, retrospective or prospective).

3. Number of Experts and Qualifications for Ground Truth

Not applicable. This device is a Balloon Dilatation Catheter, and the assessment relies on engineering and biological performance standards, not expert interpretation of medical images or clinical outcomes that typically require expert ground truth establishment.

4. Adjudication Method

Not applicable. As noted above, this submission focuses on bench testing against established standards and design specifications, not on subjective clinical assessments requiring adjudication.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No. The document explicitly states: "No Clinical test is included in this submission." Therefore, no MRMC study was conducted.

6. Standalone Performance Study

Yes, a standalone performance study in the form of non-clinical bench testing was conducted to evaluate the device against its design specifications and relevant medical device standards. The "Performance Data" section details the various aspects tested (e.g., head tip, connect strength, leakage, balloon fatigue, etc.).

7. Type of Ground Truth Used

The "ground truth" for the performance evaluation was based on:

  • Design specifications: The device's performance was compared against its own pre-defined engineering and functional requirements.
  • Relevant medical device standards: Specifically, ISO 10993 for biocompatibility and ISO 11135 for sterility. While not explicitly named for other tests, it's implied that recognized engineering and performance standards would be followed.

8. Sample Size for the Training Set

Not applicable. This device is a physical medical device and its performance is evaluated through bench testing and conformance to standards, not through machine learning models that require training sets.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no machine learning training set for this device.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA text logo on the right. The FDA text logo is in blue and includes the letters "FDA" followed by "U.S. FOOD & DRUG ADMINISTRATION" in a smaller font size.

April 6, 2022

Hangzhou AGS MedTech Co., Ltd. Jiayuan Zhang, RA Specialist Building 5, Building 6, No.597 Kangxin Road Yuhang District Hangzhou. Zhejiang 311106 CHINA

Re: K213578 Trade/Device Name: Balloon Dilatation Catheter Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: Class II Product Code: FDF, KNQ, FDS Dated: November 4, 2021 Received: November 10, 2021

Dear Jiayuan Zhang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Shanil P. Haugen, Ph.D. Assistant Director DHT3A: Division of Renal, Gastrointestinal, Obesity and Transplant Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below.

510(k) Number (if known) K213578

Device Name Balloon Dilatation Catheter

Indications for Use (Describe)

The Balloon Dilatation Catheter is intended to endoscopically dilate strictures of the alimentary tract. The device is supplied sterile and intended for single use only.

Type of Use (Select one or both, as applicable)
-------------------------------------------------

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (6/20)

{3}------------------------------------------------

K213578 Page 1 of 6

Image /page/3/Picture/1 description: The image shows the logo for AGS Medtech. The logo consists of a circular design with three curved shapes in blue and green. To the right of the logo are the words "AGS MEDTECH" in English, followed by the same name in Chinese characters. The text is in a smaller font size than the logo itself.

510(k) Summary Balloon Dilatation Catheter

510(k) Summary

We submit this 510(k) Summary as per 21 CFR 807.92, it meets the content and format regulatory requirements.

5.1 Submitter

Submitter InformationHangzhou AGS MedTech Co., Ltd.Building 5, Building 6, No.597 Kangxin Road YuhangDistrict, 311106 Hangzhou, Zhejiang, China
EstablishmentRegistration Number:3010288205
Registration Status:Active
Contact Person:Jiayuan ZhangPhone: 0086-18668235131Fax: 0086-0571-87671225Email: zhangjy@bioags.com
Date Prepared:March 22, 2022

5.2 Proposed Device

Trade Name:Not Applicable
Device Name:Balloon Dilatation Catheter
Common Name:Balloon Dilatation Catheter
Regulatory Class:Class II
Regulation Number:21 CFR § 876.1500
Regulation Name:Endoscope and accessories,
FDA Review Panel:Gastroenterology/Urology
Product Code(s):FDF, KNQ, FDS
Product Code Name:FDF: Colonoscope And Accessories,FDS: Gastroscope And Accessories,KNQ: Dilator, Esophageal

5.3 Predicate Device

Trade Name:CRE™ Balloon Dilation Catheter
Common Name:Dilation catheter
510(k) Number:K110833
Regulatory Class:Class II
Regulation Number:21 CFR § 876.1500
Regulation Description:Endoscope and accessories
FDA Review Panel:Gastroenterology/Urology
Product Code(s):FDT, FDF, KNQ
Product Code Name:FDT: Duodenoscope And Accessories, Flexible/RigidFDF: Colonoscope And Accessories, Flexible/RigidKNQ: Dilator, Esophageal

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows a logo for AGS Medtech. The logo consists of a blue and green circular design on the left, with the text "AGS MEDTECH" in black on the right. Below the English text is the same text in Chinese characters. The logo is simple and modern, and the colors are bright and eye-catching.

K213578 Page 2 of 6

510(k) Summary Balloon Dilatation Catheter

5.4 Device Description

The proposed device Balloon Dilatation Catheter is comprised of a pebax balloon mounted at the distal end of a pebax catheter with two ports. The balloon can be inflated to three distinct sizes, 6-7-8mm, 8-9-10mm, 10-11-12mm, 12-13.5-15mm, 15-16.5-18mm, 18-19-20mm diameters; the balloon length can be 30mm, 55mm and 80mm. Radiopaque bands placed at the distal and proximal end of the device provide fluoroscopic visualization of the balloon location. The catheter length is 1800mm, 1950mm, 2100mm and 2400mm with an outer diameter of 1.8mm, 2.0mm or 2.3mm. The two ports correspond to a guide wire port and balloon inflation port. A stopcock is included at the proximal end of the balloon inflation port to control pressure movement into or out of the device. For rapid exchange models, there is a small hole on the catheter which is about 200mm far away from the distal end, it is used to insert the guide wire rapidly. The Balloon Dilatation Catheter is EO sterilization and use for single use only.

5.5 Indication for Use statement

The Balloon Dilatation Catheter is intended to endoscopically dilate strictures of the alimentary tract. The device is supplied sterile and intended for single use only.

5.6 Comparison of Technology Characteristics

Our proposed device Balloon Dilatation Catheter is substantially equivalent to the predicate devices. The differences between the Balloon Dilatation Catheter and the predicate devices do not raise any questions regarding its safety and effectiveness. The differences are listed in the table below:

{5}------------------------------------------------

Image /page/5/Figure/0 description: The image shows a logo for AGS Medtech. The logo consists of a circular design with three blue curved shapes forming a triangle, with a green shape in the center. To the right of the circular design, the text "AGS MEDTECH" is written in a smaller font size. Below that, there is Chinese text that translates to "An Jie Si Medical".

Table 5.6 Comparison of technical characteristics

ItemProposed devicePredicate deviceComparison
Trade nameNot applicableCRETM Wireguided Balloon DilatationCatheter/
Model number5251 series, 5252 seriesM00558500*****, M00558450,M00558460, M00558470, M00558480,M00558490M00558390, M00558400, M00558410,M00558420, M00558430,M00558440****/
510(k) submitterHangzhou AGS MedTechCo., Ltd.Boston ScientificCorporation/
510(k) numberK213578K110833/
ClinicalIntended useThe Balloon Dilatation Catheter is intendedto endoscopically dilate strictures of thealimentary tract. The device is suppliedsterile and intended for single use only.Indicated for use in adult and adolescentpopulations to endoscopically dilatestrictures of the alimentary tract. Therecommended application is printed on thepackage label referring to any combinationof esophageal, pyloric and colonic dilatation.Similar. Our proposed device has thesmaller applicable population range.
ApplicablepopulationAdultsAdult and adolescent populationsDifferent. Our proposed devicehas the smaller applicablepopulationrange.
PrinciplesofoperationBalloon Dilatation Catheter is a device thatoperated on the principle of inflating aballoon attached to the distal end ofcatheter, to dilate strictures of thealimentary tract. Radiopaque bands placedat the distal and proximal ends of theballoon provide fluoroscopic visualizationof the balloon location.The Balloon Dilatation Catheter is capableof 3 distinct and progressively larger sizediameters via controlled radial expansion.Specific balloon sizes are printed on eachpackage and small label.The CRE Wireguided Balloon DilatationCatheter is capable of 3 distinct andprogressively larger size diameters viacontrolled radial expansion. Specific balloonsizes are printed on each package and hublabel.Similar.
Rapid exchangeor notFor 5251 Series : NoFor 5252 series: YesNoDifferent. We use K172520 asreference device to support thistechnological characteristic.
TechnicalDevicepicture andstructureDrawing of Balloon Dilatation Catheter (for5251 series)Image: Drawing of Balloon Dilatation Catheter1.Guidewire port3.Ballooninflation5.Catheter7.Balloon2. On-off valve4.Base port6. Small label8.RadiopaquebandImage: Device picture and structureSimilar
Drawing of Balloon Dilatation Catheter (for 5252
series)
Image: Drawing of a balloon dilatation catheter
1. Guidewire portinflation5.Catheter7.Balloon9.Luer cap2.On-offvalve 3.Balloon4.Base port6.Smalllabel8.Radiopaque band10.RXsupport wire
Outer diameter1.8mm, 2.0mm, 2.3mm2.5mm (7.5Fr)Similar.
Balloon length30mm, 55mm, 80mm;55mmSimilar.Our proposed device has morespecifications to be chosen.
Working length1800mm, 1950mm,2100mm, 2400mm2400mm, 1800mmSimilar.Our proposed device has morespecifications tobe chosen.
Suitable workingchannel ofendoscopeFor 5252 series: 3.7 mm2.8 mmDifferent. We use K172520, K112994 andK122924 as reference devices to supportthis technological characteristic.
BiologicalMaterials orsubstances incontact with thesame humantissue or bodyfluidsPEBAXNo exact information.Different. Biocompatibility tests havebeen done for the difference.Biological risks are acceptable.
BiocompatibilityIn Vitro Cytotoxicity Test: ISO 10993-5: 2009;Skin sensitization Test: ISONo exact information.

Section 5 510(k) Summary
Balloon Dilatation Catheter

{6}------------------------------------------------

Image /page/6/Picture/2 description: The image contains a logo for AGS Medtech. The logo consists of a circular design with three curved shapes in blue and green. To the right of the circular design, the text "AGS MEDTECH" is written in a sans-serif font. Below "AGS MEDTECH", there is Chinese text.

Section 5 510(k) Summary

Balloon Dilatation Catheter

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image shows the logo for AGS Medtech. The logo consists of a blue and green circular design on the left, with the text "AGS MEDTECH" in black on the right. Below the English text is the same name in Chinese characters. The logo is simple and modern, and the colors are bright and eye-catching.

Section 5 510(k) Summary
Balloon Dilatation Catheter

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image shows a logo for AGS MEDTECH. The logo consists of a blue circular design with three curved arrows pointing inward, with a green shape in the center. To the right of the circular design, the text "AGS MEDTECH" is written in English, with the Chinese characters for "Anjie Si Medical" written below.

K213578 Page 6 of 6

Section 5 510(k) Summary Balloon Dilatation Catheter

10993-10: 2010;
Intracutaneous Reactivity
Test: ISO 10993-10: 2010;
Acute Systemic Toxicity Test:
ISO 10993-11:2017;
Pyrogenicity: ISO
10993-11:2017;

5.7 Applicable Guidance Document

NA

5.8 Performance Data

The Balloon Dilatation Catheter meets all design specifications and medical device standards for biocompatibility (ISO 10993) and sterility (ISO 11135). The non-clinical performance meets the design specification and shows substantial equivalence to the predicated device.

Following tests were conducted in our non-clinical bench test:

  • The head tip of the distal end;
  • Connect strength; ●
  • Leakage performance; ●
  • Balloon fatigue performance;
  • Balloon position detectability; ●
  • . Interface compatibility with endoscope;
  • Compatibility with guide wire;
  • . Compatibility with luer taper.

5.9 Clinical Test

No Clinical test is included in this submission.

5.10 Conclusion

In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807, Based on the information provided in this premarket notification, Hangzhou AGS MedTech Co., Ltd has demonstrated that proposed device Balloon Dilatation Catheter is substantially equivalent to the predicate devices.

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.